JARRELL HILL: Open Payments
NPI 1629663836 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$474 in 21 payments from 11 companies in 2025. Trend: 2023 $1,966 · 2024 $1,126 · 2025 $474
Food & beverage: $474
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $100 |
| Lilly USA, LLC | 3 | $71 |
| Exact Sciences Corporation | 3 | $56 |
| Braeburn Inc. | 2 | $46 |
| Xeris Pharmaceuticals, Inc. | 1 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| PFIZER INC. | 2 | $36 |
| ABBVIE INC. | 1 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: JARDIANCE, MOUNJARO, BRIXADI, GVOKE HYPOPEN, Kerendia, Cologuard Collection Kit, UBRELVY, REXULTI.
Industry payments across PA — which companies pay providers there.
